From: IgG-class anti-PF4/heparin antibodies and symptomatic DVT in orthopedic surgery patients receiving different anti-thromboembolic prophylaxis therapeutics
Variable
p
HR
95%CI
Age≧75 yr
0.010
2.396
(1.227-4.677)
Male Gender
0.041
0.353
(0.130-0.957)
Risk factors
0.760
1.114
(0.556-2.233)
TKA/THA
0.074
1.792
(0.944-3.401)
Seroconvertion of IgG-class HIT Ab
0.005
2.583
(1.338-4.984)